Variable | Delirium | COR &95%CI | P-value | |
---|---|---|---|---|
No(N%) | Yes(N%) | |||
Alcohol use | ||||
Lifetime | ||||
No | 267(66.58%) | 75(18.7%) | 1 | 1 |
Yes | 27(6.733%) | 32(7.98%) | 0.237(0.134–0.420) | 0.001* |
Current use | ||||
No | 21(20.8%) | 11(2.74%) | 1 | 1 |
Yes | 6(1.49%) | 21(5.23%) | 6.68(2.08–3.201) | 0.01 |
Cigaratte smoking | ||||
Lifetime | ||||
No | 291(72.56%) | 97(24.18%) | 1 | 1 |
Yes | 3(0.75%) | 10(2.49%) | 3.100(1.27–5.371) | 0.001* |
Current use | ||||
No | 6(1.49%) | 1(0.25%) | 1 | 1 |
Yes | 3(0.75%) | 3(0.75%) | 2.052(1.060–3.972) | 0.033* |
Khat use | ||||
Lifetime | ||||
No | 268(66.83%) | 68(16.95%) | 1 | 1 |
Yes | 26(6.48%) | 39(9.72%) | 0.169(0.096–0.297) | 0.004* |
Current use | ||||
No | 17(4.24%) | 14(3.49%) | 1 | 1 |
Yes | 10(2.49%) | 25(6.23%) | 0.410(0.287–0.585) | 0.031* |
Previous or current use of antipsychotics | ||||
Yes | 3(0.75%) | 18(4.48%) | 0.051(0.015–0.177) | 0.013* |
No | 291(72.56%) | 89(22.19) | 1 | 1 |
Previous or current use of benzodiazepines | ||||
Yes | 3(0.75%) | 18(4.48%) | 0.051(0.15–0.77) | 0.0043* |
No | 291(72.56%) | 89(22.19%) | 1 | 1 |
History of polytherapy | ||||
Yes | 70(17.45%) | 92(22.94%) | 0.051(0.028–0.094) | 0.0023* |
No | 224(55.86%) | 15(3.74) | 1 | 1 |
Bladder catheterization | ||||
Yes | 80(19.95%) | 77(19.2%) | 0.146(0.089–0.239) | 0.002* |
No | 214(53.36%) | 30(7.48) | 1 | 1 |
Intravenous fluid | ||||
Yes | 223(55.61%) | 107(26.68) | 0.23(0.874–1.652) | 0.99 |
No | 71(17.7) | 0(0%) | 1 | 1 |
Frequent Admission | ||||
Yes | 15(3.74%) | 43(10.72) | 0.080(0.042–0.153) | 0.0021* |
No | 279(69.57%) | 64(15.96%) | 1 | 1 |
Hearing impairment | ||||
Yes | 14(3.49%) | 19(4.73%) | 0.232(0.112–0.481) | 0.0033* |
No | 280(69.82%) | 88(21.94%) | 1 | 1 |
Vision impairment | ||||
Yes | 26(6.48%) | 28(6.98%) | 0.274(0.152–0.494) | 0.0015* |
No | 268(66.83%) | 79(19.7%) | 1 | 1 |